IP Library › Granted Patent US 11,364,304
Granted Patent B2
US 11,364,304 · App. 16/328,025 · Granted Jun 21, 2022

Crosslinked micellar spherical nucleic acids

Inventors: Chad A. Mirkin (Wilmette, IL); SonBinh T. Nguyen (Evanston, IL); Resham J. Banga (Evanston, IL)
Assignee: Northwestern University
A61K47/6917A61K31/711A61K31/7105C07H21/02C07H21/04C12N15/113C12N15/88C12N2310/11C12N2310/141
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,364,304
App. No.
16/328,025
Granted
Jun 21, 2022
Kind
B2
Abstract

Methods of preparing crosslinked spherical nucleic acids (SNAs) using thermoresponsive traceless templates, such as PEO-PPO-PEO block copolymers. The crosslinks can be added between oligonucleotides within the same SNA or oligonucleotides between multiple different SNAs.

Claims (14)

1. A crosslinked micellar spherical nucleic acid (SNA) comprising a plurality of amphiphilic oligonucleotides, and polyethyleneoxide-polypropyleneoxide-polyethyleneoxide (PEO-PPO-PEO), wherein each amphiphilic oligonucleotide comprises (i) a lipid portion and (ii) a nucleobase portion, wherein the nucleobase portion includes at least one reactive group, wherein the lipid portion is conjugated to a termini of the nucleobase portion, wherein the lipid portion of the amphiphilic oligonucleotide intercalates with the PEO-PPO-PEO, and wherein the plurality of amphiphilic oligonucleotides are crosslinked with a PEGylated crosslinking agent that comprises at least two reactive sites, each of which is capable of forming a covalent bond with the reactive groups of the amphiphilic oligonucleotides and thereby crosslinking the amphiphilic oligonucleotides.

2. The crosslinked micellar SNA of claim 1 , having a diameter of 150 nm or less.

3. The crosslinked micellar SNA of claim 1 , having at least 200 strands of amphiphilic oligonucleotides.

4. The crosslinked micellar SNA of claim 1 , wherein each amphiphilic oligonucleotide comprises an oligonucleotide sequence of 10 to 100 nucleobases.

5. The crosslinked micellar SNA of claim 1 , wherein the nucleobase portion of each amphiphilic oligonucleotide comprises a section having a therapeutic sequence.

6. The crosslinked micellar SNA of claim 1 , wherein the lipid portion of each amphiphilic oligonucleotide comprises 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dimyristoyl-sn-phosphatidylcholine (DMPC), 1-palmitoyl-2-oleoyl-sn-phosphatidylcholine (POPC), 1,2-distearoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DSPG), 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine (DOPE), or 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DPPE).

7. The crosslinked micellar SNA of claim 1 , wherein the lipid portion and the nucleobase portion of the amphiphilic oligonucleotide are connected via a triazolyl.

8. The crosslinked micellar SNA of claim 1 , wherein each amphiphilic oligonucleotide comprises RNA and the RNA is a non-coding RNA.

9. The crosslinked micellar SNA of claim 1 , wherein each amphiphilic oligonucleotide is DNA and the DNA is antisense-DNA.

10. The crosslinked micellar SNA of claim 8 , wherein the non-coding RNA is a microRNA.

11. The crosslinked micellar SNA of claim 1 , wherein the reactive group is at the 3′ end of the nucleobase portion.

12. The crosslinked micellar SNA of claim 1 , wherein the reactive group is at the 5′ end of the nucleobase portion.

13. The crosslinked micellar SNA of claim 1 , wherein the reactive group in an amine group.

14. The crosslinked micellar SNA of claim 1 , wherein the nucleobase portion comprises at least two nucleotides each having the amine reactive group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2019
From: MIRKIN, CHAD A.; NGUYEN, SONBINH T.; BANGA, RESHAM SINGH JASPAL SINGH
To: NORTHWESTERN UNIVERSITY
Reel/Frame 049289/0159 →
Continuity (2)
Provisional Application 62379352 · Aug 25, 2016
Related Publication 20190275166A1 · Sep 12, 2019